Clinical trial
Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function…
NCT00385801 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00385801 |
|---|---|
| Title | Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence |
| Official title | A Double-Blind, Placebo-Controlled Study of the Effects of Risperdal Consta on Brain Reward Circuitry, Craving and Cocaine Use in Active Cocaine Dependence |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Janssen, LP Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine Dependence |
| Intervention type | Drug |
| Interventions | Risperidone, Placebo |
| Enrollment | 31 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Oct 11, 2006 |
| Last update posted | Apr 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: